Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. According to the World Health Organization (WHO), TB is one of the top 10 causes of death worldwide, and in 2019 alone, there were an estimated 10 million cases and 1.4 million deaths. While there are treatments available for TB, there is currently only one licensed vaccine for the disease, Bacillus Calmette-Guérin (BCG).
However, BCG is not effective in preventing all forms of TB and its efficacy varies depending on geographic location and other factors. As a result, there is a need for new and more effective TB vaccines. The global Tuberculosis Vaccine Market is expected to grow significantly in the coming years, driven by several key factors. The global TB vaccine market is a critical area of focus for the global health community. The development of new and improved TB vaccines, as well as better diagnostic tools for TB, could have a significant impact on the global burden.
Read more @ https://creativeedge16.blogspot.com/2023/03/tuberculosis-vaccine-market-latest.html
